Top Markets
Coin of the day
Crystalvue Medical Corporation Crystalvue Medical Corporation

Crystalvue Medical Corporation

6527
Rank in Stocks #24453
Based in Taoyuan City, Taiwan, and established in 2009, Crystalvue Medical... Based in Taoyuan City, Taiwan, and established in 2009, Crystalvue Medical Corporation operates internationally, specializing in the design, production, and distribution of ophthalmic medical devices. Their comprehensive product range encompasses instruments like retinal cameras, tonometers, and lens edgers, in addition to various gastroenterology provisions.
Share Price
$2.38
Market Cap
$60.44M
Change (1 day)
0.00%
Change (1 year)
-16.40%
Country
TW
Trade Crystalvue Medical Corporation (6527)

Category

P/E ratio for Crystalvue Medical Corporation (6527)
P/E ratio as of 2026 TTM: 0
According to Crystalvue Medical Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Crystalvue Medical Corporation from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
44.58 -
US
30.10 -
FR
- -
JP
55.24 -
US
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.